Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How do you treat SNUC?

3
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

There’s no standard treatment. Suitable for gross total resection: surgery and postop RT and concomitant chemo.Not suitable for GTR: chemo RT or induction chemo and reevaluate for surgery and postop RT chemo.

Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Yes, FAST-Forward is fine after oncoplastic reduction as long as dose homogeneity criteria can be met (V105 < 5%).

Do you attempt to spare the submandibular glands in head and neck IMRT?

6
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · UTMB

I do too. The primaries I consider electively treating 1B nodal station are: oral cavity, nose and anterior nasal cavity, lip, medial cheek/mid face, and node positive parotid. The submandibular gland itself is devoid of lymph nodes and is rarely ever involved by Sq cell Ca (versus the parotid gland...

What dose and OAR constraints do you use for boost with IMRT or SBRT when a patient with cancer of the cervix is not a candidate for brachytherapy?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · UAB Department of Radiation Oncology

Concurrent chemoradiotherapy plus brachytherapy boost (intracavitary or interstitial) is the standard of care in patients with locally advanced cervical cancer. In light of published data suggesting inferior survival if brachytherapy is omitted from definitive treatment, we do not recommend utilizin...

For locally advanced adenocarcinoma of the maxillary sinus, how should the neck be managed?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

ENI if high grade

Would you add a brachytheray boost to a locally advanced cervical cancer after surgical resection and pelvic RT?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Radiation Oncology And Cyberknife Treatment Ctr

In general, a brachytherapy boost following external radiation is not standard when treating women for locally advanced cervical cancer post hysterectomy. Neither of the 2 major adjuvant GOG trials (92 and 109) allowed a brachytherapy boost, and even the currently open GOG trial, GOG 263, does not i...

Which normal brain dosimetric constraints are most important when treating brain mets with SRS?

4
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Northeast Alabama Regional Medical Center

Great point, esp. about the PTV margin issue. Some people argue you don't really need to add a mm or two of margin; "We have sub-mm localization error." A 0.7 mm error in three single dimensions equals a 1.2 mm error for the scalar in 3D (as 1.2 = ((0.7^2)+(0.7^2)+(0.7^2))^0.5), so I think it's a si...

What approach do you take to determine dose constraints for conventionally fractionated reirradiation of the head and neck?

3
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · NYC Health + Hospitals

Great question, very challenging scenario.In general, try to minimize the margins for re-RT, and use IGRT, especially if you are close to the neurologic critical structures. (Optics, brainstem, spinal cord, plexus, temporal lobe.)Specific doses and whether you exceed limits: that really depends on w...

Would you consider starting immunotherapy concurrently with whole brain radiation for newly diagnosed metastatic (BRAF negative) melanoma with multifocal symptomatic brain metastases?

2 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Colorado

This is a challenging clinical situation. In part, the approach depends on the number and size of the CNS lesions. However, I do not recommend the use of WBRT for my patients, as it has not demonstrated a survival benefit. In addition, in the adjuvant trial comparing WBRT to observation, it did not ...

What are the indications for adjuvant radiotherapy for basal cell carcinoma of the skin of the head and neck?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan Kettering Cancer Center

I rarely give adjuvant radiotherapy for resected BCCs because there is little data demonstrating a benefit. For BCCs, with squamous features or nodal metastases, I generally manage as a cSCC. Some reasons to consider adjuvant RT to resected BCC primary tumor might be: -T3/T4 primary (by AJCC 7) -R2 ...